DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Files An 8-K Results of Operations and Financial Condition

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Files An 8-K Results of Operations and Financial Condition
Item 2.02. – Results of Operations and Financial Condition

Story continues below

The following information is furnished to Item 2.02, “Results of Operations and Financial Condition.”

On March1, 2019, the Company issued a press release disclosing its preliminaryfourth quarter and full year sales and earnings. This earnings release references net sales, excluding precious metal content, and net income, adjusted for certain charges, both of which are considered measures not calculated in accordance with generally accepted accounting principles in the United States of America (non-US GAAP measures). Due to the fluctuations of precious metal prices and because the precious metal content of the Company’s sales is largely a pass-through to customers and has minimal effect on earnings, the Company reports sales both with and without precious metal content to show the Company’s performance independent of precious metal price volatility and to enhance comparability of performance between periods. Earnings from operations, adjusted for certain charges, are presented to enhance the comparability between periods. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference.

Item 9.01. – Financial Statements and Exhibits

(d) Exhibits:

99.1 The DENTSPLY SIRONA Inc. Preliminary Fourth Quarter and Full Year earnings release issued March 1, 2019 as referenced in Item 2.02.

DENTSPLY SIRONA Inc. Exhibit
EX-99.1 2 ex991-2018q410xk.htm EXHIBIT 99.1 DocumentDentsply Sirona Reports Preliminary Fourth Quarter and Full Year 2018 Results•Reported Q4 revenues of $1,…
To view the full exhibit click here

About DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. The Company’s segments include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses. The Company’s principal product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company distributes its products in over 120 countries. It offers brands, such as ANKYLOS, AQUASIL ULTRA, ARTICADENT, XIVE, ORAQIX, XYLOCAINE, ZHERMACK, IN-OVATION, LOFRIC, MAILLEFER, MIDWEST, NUPRO, ORIGO, OSSEOSPEED and PALODENT PLUS.

An ad to help with our costs